Takeda Pharmaceutical Company Limited Adjustments For Unrealised Foreign Exchange Losses Gains
Takeda Pharmaceutical Company Limited (TKPHF) reported Adjustments For Unrealised Foreign Exchange Losses Gains of JPY 0 for the 12-month period ending 2022-03-31, per its 20-F filed 2022-06-29.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2022-06-29
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2022-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2021-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 399.00M JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -2.67B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 41.47B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 0.00 JPY 20-F · filed 2019-06-27 |